Table 1 Demographic and preoperative characteristics of patients
From: Efficacy and safety of primary posterior capsulotomy during phaco-vitrectomy for epiretinal membrane
Characteristics | Capsulotomy (−) group (n = 152) | Capsulotomy (+) group (n = 76) | P value |
|---|---|---|---|
Age (years), mean ± SD | 67.45 ± 6.60 | 65.68 ± 6.95 | 0.062* |
Sex (female), n (%) | 109 (71.7%) | 44 (57.9%) | 0.036† |
DM, n (%) | 20 (13.2%) | 11 (14.5%) | 0.785† |
HTN, n (%) | 58 (38.2%) | 25 (32.9%) | 0.436† |
Follow-up duration (months), mean ± SD | 11.41 ± 1.80 | 10.97 ± 2.27 | 0.118* |
ERM stage, n (%) | 0.124† | ||
Stage 1 | 34 (22.4%) | 9 (11.8%) | |
Stage 2 | 32 (21.1%) | 12 (15.8%) | |
Stage 3 | 60 (39.5%) | 38 (50.0%) | |
Stage 4 | 26 (17.1%) | 17 (22.4%) | |
Baseline BCVA (logMAR), mean ± SD | 0.308 ± 0.204 | 0.344 ± 0.229 | 0.233* |
Baseline CMT (μm), mean ± SD | 412.75 ± 112.48 | 483.37 ± 100.59 | 0.000* |